Steven C Gilman - Net Worth and Insider Trading
Steven C Gilman Net Worth
The estimated net worth of Steven C Gilman is at least $771,227 dollars as of 2024-04-27. Steven C Gilman is the Director of Momenta Pharmaceuticals Inc and owns about 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) stock worth over $409,134. Steven C Gilman is the Director of Vericel Corp and owns about 5,200 shares of Vericel Corp (VCEL) stock worth over $239,460. Steven C Gilman is also the Director of Keryx Biopharmaceuticals Inc and owns about 17,333 shares of Keryx Biopharmaceuticals Inc (KERX) stock worth over $58,239. Besides these, Steven C Gilman also holds Akebia Therapeutics Inc (AKBA) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) . Details can be seen in Steven C Gilman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven C Gilman has not made any transactions after 2022-06-03 and currently still holds the listed stock(s).
Transaction Summary of Steven C Gilman
Steven C Gilman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven C Gilman owns 6 companies in total, including Momenta Pharmaceuticals Inc (MNTA) , SCYNEXIS Inc (SCYX) , and Akebia Therapeutics Inc (AKBA) among others .
Click here to see the complete history of Steven C Gilman’s form 4 insider trades.
Insider Ownership Summary of Steven C Gilman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2020-10-01 | director |
| SCYX | SCYNEXIS Inc | 2023-06-15 | director |
| AKBA | Akebia Therapeutics Inc | 2022-06-03 | director |
| CFRXQ | ContraFect Corp | 2017-07-25 | director |
| VCEL | Vericel Corp | 2022-04-29 | director |
| KERX | Keryx Biopharmaceuticals Inc | 2018-12-12 | director |
Steven C Gilman Latest Holdings Summary
Steven C Gilman currently owns a total of 6 stocks. Among these stocks, Steven C Gilman owns 7,796 shares of Momenta Pharmaceuticals Inc (MNTA) as of August 5, 2020, with a value of $409,134 and a weighting of 53.05%. Steven C Gilman owns 5,200 shares of Vericel Corp (VCEL) as of April 29, 2022, with a value of $239,460 and a weighting of 31.05%. Steven C Gilman also owns 17,333 shares of Keryx Biopharmaceuticals Inc (KERX) as of June 11, 2018, with a value of $58,239 and a weighting of 7.55%. The other 3 stocks Akebia Therapeutics Inc (AKBA) , SCYNEXIS Inc (SCYX) , ContraFect Corp (CFRXQ) have a combined weighting of 8.35% among all his current holdings.
Latest Holdings of Steven C Gilman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MNTA | Momenta Pharmaceuticals Inc | 2020-08-05 | 7,796 | 52.48 | 409,134 |
| VCEL | Vericel Corp | 2022-04-29 | 5,200 | 46.05 | 239,460 |
| KERX | Keryx Biopharmaceuticals Inc | 2018-06-11 | 17,333 | 3.36 | 58,239 |
| AKBA | Akebia Therapeutics Inc | 2022-06-03 | 43,430 | 1.34 | 58,196 |
| SCYX | SCYNEXIS Inc | 2020-12-21 | 4,000 | 1.54 | 6,160 |
| CFRXQ | ContraFect Corp | 2017-07-25 | 2,080 | 0.02 | 37 |
Holding Weightings of Steven C Gilman
Steven C Gilman Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven C Gilman has made a total of 3 transactions in Momenta Pharmaceuticals Inc (MNTA) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Momenta Pharmaceuticals Inc is the sale of 13,000 shares on August 5, 2020, which brought Steven C Gilman around $425,750.
According to the SEC Form 4 filings, Steven C Gilman has made a total of 5 transactions in Vericel Corp (VCEL) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Vericel Corp is the sale of 900 shares on April 29, 2022, which brought Steven C Gilman around $27,846.
According to the SEC Form 4 filings, Steven C Gilman has made a total of 0 transactions in Keryx Biopharmaceuticals Inc (KERX) over the past 5 years. The most-recent trade in Keryx Biopharmaceuticals Inc is the sale of 1,334 shares on June 11, 2018, which brought Steven C Gilman around $6,830.
More details on Steven C Gilman's insider transactions can be found in the Insider Trading History of Steven C Gilman table.Insider Trading History of Steven C Gilman
- 1
Steven C Gilman Trading Performance
GuruFocus tracks the stock performance after each of Steven C Gilman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven C Gilman is 54.51%. GuruFocus also compares Steven C Gilman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven C Gilman within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven C Gilman's insider trading performs compared to the benchmark.
Performance of Steven C Gilman
Average Return
9.6%
Outperforming Transactions
50%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 23.22 | 54.51 | 67.13 | 9.6 | -26.35 | -38.6 |
| Relative Return to S&P 500(%) | 21.56 | 50.49 | 59.51 | -7.74 | -38.74 | -48.11 |
Steven C Gilman Ownership Network
Ownership Network List of Steven C Gilman
Ownership Network Relation of Steven C Gilman
Steven C Gilman Owned Company Details
What does Momenta Pharmaceuticals Inc do?
Who are the key executives at Momenta Pharmaceuticals Inc?
Steven C Gilman is the director of Momenta Pharmaceuticals Inc. Other key executives at Momenta Pharmaceuticals Inc include Chief Legal Officer Alejandra Carvajal , Chief Scientific Officer Anthony M. Manning , and SVP & Chief Medical Officer Santiago Arroyo .
Momenta Pharmaceuticals Inc (MNTA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Momenta Pharmaceuticals Inc (MNTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Momenta Pharmaceuticals Inc (MNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Momenta Pharmaceuticals Inc (MNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Momenta Pharmaceuticals Inc Insider Transactions
Steven C Gilman Mailing Address
Above is the net worth, insider trading, and ownership report for Steven C Gilman. You might contact Steven C Gilman via mailing address: 110 Hartwell Avenue, Lexington Ma 02421.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
